CDER risk assessment exercise to evaluate potential risks from the use of nanomaterials in drug products.

Saved in:
Bibliographic Details
Title: CDER risk assessment exercise to evaluate potential risks from the use of nanomaterials in drug products.
Authors: Cruz CN; Center for Drug Evaluation and Research, United States Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA., Tyner KM, Velazquez L, Hyams KC, Jacobs A, Shaw AB, Jiang W, Lionberger R, Hinderling P, Kong Y, Brown PC, Ghosh T, Strasinger C, Suarez-Sharp S, Henry D, Van Uitert M, Sadrieh N, Morefield E
Source: The AAPS journal [AAPS J] 2013 Jul; Vol. 15 (3), pp. 623-8. Date of Electronic Publication: 2013 Mar 20.
Publication Type: Journal Article
Journal Info: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1550-7416
DOI:10.1208/s12248-013-9466-6